Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04144738 · ClinicalTrials.gov registry record
Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"
A clinical trial, sponsored by Exact Sciences Corporation.
- Completed
- Registry status
- 26,758
- Enrollment target
NCT04144738 is a clinical trial that has completed, run by Exact Sciences Corporation. The registered enrollment target is 26,758 participants.
The verdict
NCT04144738 has completed, sponsored by Exact Sciences Corporation.
- COMPLETED
- Registry status
- 26,758 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.
Interventions
- PROCEDURE Colonoscopy
- DIAGNOSTIC_TEST mt-sDNA 2.0 screening test
- DIAGNOSTIC_TEST FIT test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26,758 participants |
| Start Date | 2019-11-15 |
| Est. Completion | 2023-03-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04144738
The ClinicalTrials.gov registry entry for NCT04144738 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 26,758 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Exact Sciences Corporation, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Colonoscopy is the first listed.
NCT04144738 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04144738 about?
NCT04144738 is a clinical study titled "Clinical Validation of An Optimized Multi-Target Stool DNA (Mt-sDNA 2.0) Test, for Colorectal Cancer Screening "BLUE-C"". The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.
What is the current status of trial NCT04144738?
This trial is currently completed. The enrollment target is 26,758 participants. The study started on 2019-11-15. Estimated completion is 2023-03-30.
What interventions are being tested in trial NCT04144738?
The interventions under investigation include: Colonoscopy (PROCEDURE), mt-sDNA 2.0 screening test (DIAGNOSTIC_TEST), FIT test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04144738?
This trial is sponsored by Exact Sciences Corporation, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.